CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FAMEWO, C. E.
Right arrow Articles by NAGUIB, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by FAMEWO, C. E.
Right arrow Articles by NAGUIB, M.

Canadian Journal of Anesthesia, Vol 32, 533-537, Copyright © 1985 by Canadian Anesthesiologists' Society

Spinal Anaesthesia with Meperidine as the Sole Agent

C. E. FAMEWO MB BS FRCPC1 and M. NAGUIB MB BCH MSC1

1 Department of Anesthesiology, King Faisal University, King Fahd Hospital, Al-Khobar, Saudi Arabia

Address correspondence to: Dr. C.E. Famewo, Department of Anesthesiology, King Faisal University, King Fahd Hospital, P.O. Box 2208, Al-Khobar, Saudi Arabia 31952.

Twenty male patients of ASA physical status I or II undergoing surgery of the perineal or inguinal areas received intrathecal meperidine in a dose of 1 mg·kg-1 as the sole anaesthetic agent. There was sensory and motor block within ten minutes of intrathecal injection of meperidine and surgery was performed with complete analgesia. The duration of surgery was 39.7 ± 14 (mean ± SD) minutes.

Prolonged postoperative analgesia was obtained and some patients did not require additional narcotic analgesic during the postoperative period, lasting up to seven days. Side effects included nausea and vomiting (six patients), hypotension (five patients), pruritus (five patients) and urinary retention (two patients). There was no early or late respiratory depression. It is concluded that intrathecal meperidine in a dose of 1 mg·kg-1 is effective as the sole agent for spinal anaesthesia and produces prolonged postoperative analgesia. It offers an advantage for such painful operations as haemorrhoidectomy and anal fissurectomy where its prolonged analgesic effect is desirable. It could also serve as an alternative agent for spinal anaesthesia when a local anaesthetic is not available.

Key Words: ANAESTHETIC TECHNIQUES: spinal anesthesia • ANALGESIC: meperidine • PAIN: postoperative




This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
M. J. Paech, K. F. Ilett, L. P. Hackett, M. Page-Sharp, and R. W. Parsons
Disposition and Clinical Outcome After Intraperitoneal Meperidine and Ropivacaine Administration During Laparoscopic Surgery
Anesth. Analg., January 1, 2008; 106(1): 278 - 286.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
S. T. Colbert, K. Moran, D. M. O'Hanlon, F. Chambers, D. C. Moriarty, and W. P. Blunnie
An Assessment of the Value of Intraperitoneal Meperidine for Analgesia Postlaparoscopic Tubal Ligation
Anesth. Analg., September 1, 2000; 91(3): 667 - 670.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by the Canadian Anesthesiologists' Society.